» Articles » PMID: 11487022

Tissue Factor--a Receptor Involved in the Control of Cellular Properties, Including Angiogenesis

Overview
Journal Thromb Haemost
Publisher Thieme
Date 2001 Aug 7
PMID 11487022
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue factor (TF), the major initiator of blood coagulation, serves as a regulator of angiogenesis, tumor growth and metastasis. In several models, TF expression mediates upregulation of the proangiogenic vasular endothelial growth factor (VEGF) that can directly act on endothelial cells to promote vessel formation. This occurs through ligand binding, activation of signaling cascades, signal transduction and alteration of growth factor expression and is mediated by both, coagulation-dependent and -independent pathways. Depending on the cell type and the biological settings, TF seems to affect cellular properties through (i) factor VIIa (FVIIa)-dependent proteolysis of factor Xa (FXa) and thrombin and subsequent activation of proteinase activated receptor (PAR) -1 and PAR-2, (ii) through direct FVIIa signaling and mitogen activated protein (MAP) kinase activation, that is conferred by a not yet identified receptor, (iii) through interaction of FVII(a) proteolytic activity and signaling of the cytoplasmic domain and (iv) through cytoplasmic signaling independent of ligand binding. The role of phosphorylation of the cytoplasmic domain and the pathways controlling phosphorylation of TF remain poorly understood.

Citing Articles

Management of a Patient with Cardiovascular Disease Should Include Assessment of Primary and Secondary Immunodeficiencies: Part 2-Secondary Immunodeficiencies.

Napiorkowska-Baran K, Doligalska A, Drozd M, Czarnowska M, Laszczych D, Dolina M Healthcare (Basel). 2024; 12(19).

PMID: 39408157 PMC: 11477378. DOI: 10.3390/healthcare12191977.


Combining gene status with preoperative D‑dimer levels as a predictive marker of venous thromboembolism risk in patients with resectable colorectal cancer: A prospective cohort study.

Xu D, He Y, Liao C, Tan J Biomed Rep. 2024; 20(6):96.

PMID: 38765860 PMC: 11099602. DOI: 10.3892/br.2024.1784.


KRAS-mutant colorectal cancer cell lines cause a prothrombotic state through the upregulation of thrombin: experimental study.

Xu D, Liao C, Tan J Ann Med Surg (Lond). 2024; 86(2):850-855.

PMID: 38333285 PMC: 10849412. DOI: 10.1097/MS9.0000000000001645.


The Role of Tissue Factor In Signaling Pathways of Pathological Conditions and Angiogenesis.

Heidari Z, Naeimzadeh Y, Fallahi J, Savardashtaki A, Razban V, Khajeh S Curr Mol Med. 2023; 24(9):1135-1151.

PMID: 37817529 DOI: 10.2174/0115665240258746230919165935.


Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer.

Ahmadi S, Shabannezhad A, Kahrizi A, Akbar A, Safdari S, Hoseinnezhad T Biomark Res. 2023; 11(1):60.

PMID: 37280670 PMC: 10242999. DOI: 10.1186/s40364-023-00504-6.